Azithromycin






452 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1667256 Stimulation with cytokines enhances penetration of azithromycin into human macrophages. Antimicrob Agents Chemother 1991 Dec 2
2 2154437 Comparison of the acid stability of azithromycin and erythromycin A. J Antimicrob Chemother 1990 Jan 2
3 2844210 Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model. Arch Otolaryngol Head Neck Surg 1988 Nov 1
4 2847507 Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes. Agents Actions 1988 Aug 2
5 7952797 Distribution of orally administered azithromycin in various blood compartments. Int J Clin Pharmacol Ther 1994 Jul 1
6 8158029 Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. J Infect Dis 1994 Mar 1
7 8280403 Adverse effects of macrolide antibacterials. Drug Saf 1993 Nov 1
8 8539079 [Azithromycin and genital infections]. Pathol Biol (Paris) 1995 Jun 1
9 8547740 Macrolides versus azalides: a drug interaction update. Ann Pharmacother 1995 Sep 1
10 8830663 Hyperactivity of cathepsin B and other lysosomal enzymes in fibroblasts exposed to azithromycin, a dicationic macrolide antibiotic with exceptional tissue accumulation. FEBS Lett 1996 Oct 7 1
11 9145822 Effect of combination therapy of rifampicin and azithromycin on TNF levels during a rat model of chronic osteomyelitis. J Antimicrob Chemother 1997 Apr 1
12 9292586 Prophylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS: a cost-effectiveness analysis. J Acquir Immune Defic Syndr Hum Retrovirol 1997 Aug 1 3
13 9727572 Preventing Mycobacterium avium complex in patients who are using protease inhibitors: a cost-effectiveness analysis. AIDS 1998 Aug 20 1
14 10052900 Lysosomal alterations induced in cultured rat fibroblasts by long-term exposure to low concentrations of azithromycin. J Antimicrob Chemother 1998 Dec 1
15 10221415 Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 1999 Feb 2
16 10223943 Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob Agents Chemother 1999 May 1
17 10348770 Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis. Antimicrob Agents Chemother 1999 Jun 1
18 10390202 Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis. Antimicrob Agents Chemother 1999 Jul 1
19 10766581 Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med 2000 Apr 13 2
20 10839761 The ACADEMIC study in perspective (Azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia). J Infect Dis 2000 Jun 4
21 10847234 The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000 Jun 1
22 10853849 Effects of azithromycin on ozone-induced airway neutrophilia and cytokine release. Eur Respir J 2000 May 2
23 10874380 The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS. Int J Technol Assess Health Care 1999 Summer 2
24 11015162 Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. Ann Intern Med 2000 Oct 3 1
25 11073759 A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus. Clin Infect Dis 2000 Nov 1
26 11389120 The effect of azithromycin and clarithromycin on ex vivo interleukin-8 (IL-8) release from whole blood and IL-8 production by human alveolar macrophages. J Antimicrob Chemother 2001 Jun 4
27 11714218 Possible interaction between intravenous azithromycin and oral cyclosporine. Pharmacotherapy 2001 Nov 1
28 11798706 [An experimental study on the effect of azithromycin treatment in bleomycin-induced pulmonary fibrosis of rats]. Zhonghua Nei Ke Za Zhi 1999 Oct 4
29 11867823 Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax 2002 Mar 3
30 11901039 Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. Circulation 2002 Mar 19 1
31 12200967 Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts. J Periodontal Res 2002 Aug 2
32 12208321 Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. Eur J Pharmacol 2002 Aug 30 1
33 12384353 Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. Antimicrob Agents Chemother 2002 Nov 8
34 12431870 Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes. Int J Antimicrob Agents 2002 Nov 2
35 12433117 Isocratic liquid chromatographic method for the analysis of azithromycin and its structurally related substances in bulk samples. J Chromatogr Sci 2002 Oct 1
36 12435295 Intervention by azithromycin on bleomycin-induced lung injury in rats and its mechanisms. Zhonghua Jie He He Hu Xi Za Zhi 2002 Jul 4
37 12623273 Infection of human fibroblast-like synovial cells with Chlamydia trachomatis results in persistent infection and interleukin-6 production. Microb Pathog 2003 Feb 1
38 12712826 [Comparative analysis of the effectiveness and costs of azithromycin and cefoperazone treatment of patients during COPD exacerbation]. Pol Merkur Lekarski 2003 Jan 2
39 12742010 Influence of a 3-day regimen of azithromycin on the disposition kinetics of cyclosporine A in stable renal transplant patients. Pharmacol Res 2003 Jun 1
40 12907132 Macrolide antibiotics inhibit prostaglandin E2 synthesis and mRNA expression of prostaglandin synthetic enzymes in human leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003 Oct 3
41 14551160 Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release. Am J Respir Cell Mol Biol 2004 Apr 3
42 14744620 Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats. Eur J Pharmacol 2004 Jan 26 6
43 14982769 Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin. Antimicrob Agents Chemother 2004 Mar 9
44 15002174 [Immuno-modulating properties of a macrolide antibiotic "Z-factor"]. Antibiot Khimioter 2003 1
45 15163653 Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J Antimicrob Chemother 2004 Jul 1
46 15251115 Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL. Int Immunopharmacol 2004 Sep 3
47 15252403 Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae. J Lab Clin Med 2004 Jul 5
48 15325428 Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro. Int J Antimicrob Agents 2004 Sep 2
49 15328111 Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells. Antimicrob Agents Chemother 2004 Sep 4
50 15336223 Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy. Lancet Infect Dis 2004 Sep 1